Filing Details
- Accession Number:
- 0001493152-21-025348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-13 19:08:46
- Reporting Period:
- 2021-10-11
- Accepted Time:
- 2021-10-13 19:08:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
318306 | Abeona Therapeutics Inc. | ABEO | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1884342 | M. Brendan O'malley | 1330 Avenue Of The Americas, 33Rd Floor New York NY 10019 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-10-11 | 25,734 | $0.90 | 222,510 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading planadopted by Brendan O'Malley on February 24, 2021.
- The price reported in Column 4 is a weighted average price. The shares weresold in multiple transactions at prices ranging from $0.89 to $0.9625, inclusive.The reporting person undertakes to provide to the Issuer, any security holder,or the Staff of the SEC, upon request, full information regarding the number ofshares disposed at each separate price within the ranges set forth in thisfootnote.